Alternatived Products of [ 74316-55-5 ]
Product Details of [ 74316-55-5 ]
CAS No. : 74316-55-5
MDL No. : MFCD04966995
Formula :
C10 H8 BrN
Boiling Point :
-
Linear Structure Formula : -
InChI Key : REIFWJGDIKRUSB-UHFFFAOYSA-N
M.W :
222.08
Pubchem ID : 4715022
Synonyms :
Calculated chemistry of [ 74316-55-5 ] Expand+
Physicochemical Properties
Num. heavy atoms :
12
Num. arom. heavy atoms :
10
Fraction Csp3 :
0.1
Num. rotatable bonds :
0
Num. H-bond acceptors :
1.0
Num. H-bond donors :
0.0
Molar Refractivity :
54.41
TPSA :
12.89 Ų
Pharmacokinetics
GI absorption :
High
BBB permeant :
Yes
P-gp substrate :
No
CYP1A2 inhibitor :
Yes
CYP2C19 inhibitor :
Yes
CYP2C9 inhibitor :
No
CYP2D6 inhibitor :
No
CYP3A4 inhibitor :
No
Log Kp (skin permeation) :
-5.35 cm/s
Lipophilicity
Log Po/w (iLOGP) :
2.33
Log Po/w (XLOGP3) :
3.25
Log Po/w (WLOGP) :
3.31
Log Po/w (MLOGP) :
2.85
Log Po/w (SILICOS-IT) :
3.6
Consensus Log Po/w :
3.07
Druglikeness
Lipinski :
0.0
Ghose :
None
Veber :
0.0
Egan :
0.0
Muegge :
1.0
Bioavailability Score :
0.55
Water Solubility
Log S (ESOL) :
-3.88
Solubility :
0.0292 mg/ml ; 0.000132 mol/l
Class :
Soluble
Log S (Ali) :
-3.19
Solubility :
0.142 mg/ml ; 0.000639 mol/l
Class :
Soluble
Log S (SILICOS-IT) :
-4.95
Solubility :
0.00251 mg/ml ; 0.0000113 mol/l
Class :
Moderately soluble
Medicinal Chemistry
PAINS :
0.0 alert
Brenk :
0.0 alert
Leadlikeness :
1.0
Synthetic accessibility :
1.38
Application In Synthesis of [ 74316-55-5 ]
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Upstream synthesis route of [ 74316-55-5 ]
1
[ 74316-55-5 ]
[ 928839-62-7 ]
Yield Reaction Conditions Operation in experiment
62%
With chromium(VI) oxide; sulfuric acid In water at 90℃; for 2 h;
Step 2: S-bromoquinoline-S-carboxylic acidA solution (0.1 M) of 5-bromo-8-methylquinoline (from Step 1) in H2SOzrH2O (3:2) was treated with Cr?3 (10 eq.) at 900C. The reaction mixture was heated at 900C for 2 h. Then, the mixture was poured into ice and the precipitate was filtered affording (62percent) the title compound as an orange solid; MS (ES+) m/z 252, 254 (M+H)+.
Reference:
[1] Bioorganic and Medicinal Chemistry, 2010, vol. 18, # 8, p. 2836 - 2848
[2] Patent: WO2007/28789, 2007, A1, . Location in patent: Page/Page column 34
[3] Patent: WO2013/96194, 2013, A1,
[4] Patent: WO2015/84842, 2015, A1, . Location in patent: Paragraph 0089
[5] Patent: WO2009/141386, 2009, A1, . Location in patent: Page/Page column 162; 163